Stocks and Investing Stocks and Investing
Fri, April 1, 2022
[ 12:00 AM ] - WOPRAI
Elizabeth Anderson Maintained (WBA) at Hold and Held Target at $48 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Adrienne Yih Downgraded (URBN) to Hold and Decreased Target to $29 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Vincent Caintic Initiated (UPST) at Hold and Held Target at $124 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
Andrew Steinerman Downgraded (UNF) to Sell and Decreased Target to $178 on, Apr 1st, 2022
[ 12:00 AM ] - WOPRAI
George Choi Upgraded (WYNN) to Strong Buy and Decreased Target to $97 on, Apr 1st, 2022
Thu, March 31, 2022
[ 12:00 AM ] - WOPRAI
Rayna Kumar Initiated (WU) at Hold and Held Target at $19 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Do Kim Initiated (TVTX) at Buy and Held Target at $42 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Jim Duffy Initiated (WRBY) at Hold and Held Target at $36 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Scott Siefers Maintained (WFC) at Buy with Decreased Target to $63 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brian Dobson Initiated (WBX) at Strong Buy and Held Target at $19 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Edward Nash Initiated (VTYX) at Strong Buy and Held Target at $30 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (VRTX) at Hold and Held Target at $269 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Gaurav Jain Upgraded (VGR) to Buy and Increased Target to $16 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Michael Ng Maintained (COMP) at Strong Buy with Decreased Target to $12 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Eric Beaumont Maintained (CNP) at Buy with Increased Target to $32 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Erik Woodring Upgraded (CDW) to Buy and Increased Target to $214 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Alexander Pearce Upgraded (CCJ) to Buy and Increased Target to $42 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Peter Sazel Initiated (SNOW) at Hold and Held Target at $240 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Derek Johnston Maintained (SPG) at Strong Buy with Decreased Target to $173 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Javier Martinez Downgraded (SQM) to Sell and Increased Target to $70 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Steven Pizzella Maintained (SRAD) at Strong Buy with Decreased Target to $20 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Michael Graham Maintained (SRAD) at Strong Buy with Decreased Target to $25 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Stephen Laws Upgraded (STWD) to Strong Buy and Held Target at $32 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Katy Huberty Maintained (STX) at Hold with Decreased Target to $99 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Steven Chubak Downgraded (STT) to Hold and Held Target at $101 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Matthew Bouley Downgraded (TMHC) to Hold and Decreased Target to $33 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Marcelo Santos Upgraded (TIGO) to Buy on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (AVAH) at Buy with Decreased Target to $9 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
John Ransom Maintained (AVAH) at Strong Buy with Decreased Target to $8 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (ATAI) at Hold with Decreased Target to $9 on, Mar 31st, 2022

Brian Abrahams Maintained (ATAI) at Hold with Decreased Target to $9 on, Mar 31st, 2022


Published on 2024-10-27 20:15:26 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Atai Life Sciences N.V." (ATAI) at Hold with Decreased Target from $12 to $9 on, Mar 31st, 2022.

Brian has made no other calls on ATAI in the last 4 months.



There is 1 other peer that has a rating on ATAI. Out of the 1 peers that are also analyzing ATAI, 0 agree with Brian's Rating of Hold.



This is the rating of the analyst that currently disagrees with Brian

  • Michael Okunewitch of "Maxim Group" Initiated at Strong Buy and Held Target at $25 on, Tuesday, November 30th, 2021
Contributing Sources